Cormorant Asset Management, LP Praxis Precision Medicines, Inc. Transaction History

Cormorant Asset Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.83 - $1.18 $7.89 Million - $11.2 Million	9,500,000 New	9,500,000 $10.9 Million
Q2 2022 Aug 15, 2022	SELL	$1.75 - $11.34 $1.32 Million - $8.53 Million	-752,406 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$16.76 - $22.99 $4.55 Million - $6.25 Million	-271,755 Reduced 26.53%	752,406 $14.8 Million
Q3 2021 Nov 15, 2021	BUY	$13.15 - $22.56 $210 - $360	16 Added 0.0%	1,024,161 $18.9 Million
Q2 2021 Aug 16, 2021	SELL	$18.28 - $33.05 $914,000 - $1.65 Million	-50,000 Reduced 4.65%	1,024,145 $18.7 Million
Q4 2020 Feb 16, 2021	BUY	$27.25 - $55.82 $29.3 Million - $60 Million	1,074,145 New	1,074,145 $57.7 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.